Clinical Trials Browser

Phase 1 × Prostatic Neoplasms, Castration-Resistant × enzalutamide × Clear all

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05743621 2025-11-21

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT05252390 2025-11-06

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Phase 1 Terminated

82 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Triple Negative Breast Neoplasms

NCT02204072 2025-07-15

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

Phase 1 Completed

120 enrolled 28 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant

Clinical Trials

AMX-500

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)